Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dose and regimen for HDM2-p53 interaction inhibitors

Dose and regimen for HDM2-p53 interaction inhibitors

US Patent 10966978 · Granted Apr 6, 2021

Estimated economic value: $23,249,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy with an anti-CD25 antibody-drug conjugate2023
Dosage regimes for the administration of an anti-CD25 ADC2022
Intermittent dosing of MDM2 inhibitor2022
Intermittent dosing of MDM2 inhibitor2022
GDF-15 as a haematological toxicity biomarker2021
GDF-15 as a haematological toxicity biomarker2021
GDF-15 as a haematological toxicity biomarker2021
Combination therapy with an anti-axl antibody-drug conjugate2020
Pharmaceutical combinations2019
Pharmaceutical combinations2019
Markers associated with human double minute 2 inhibitors2016